{"nctId":"NCT06603766","briefTitle":"Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate","startDateStruct":{"date":"2021-10-01","type":"ACTUAL"},"conditions":["Magnesium Sulfate - PPHN"],"count":40,"armGroups":[{"label":"Nebulized magnesium (NebMag) group 1","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Inhalational magnesium sulfate"]},{"label":"Intravenous magnesium (IVMag) group 2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: IV Magnesium Sulfate"]}],"interventions":[{"name":"IV Magnesium Sulfate","otherNames":["IV MgSO4"]},{"name":"Inhalational magnesium sulfate","otherNames":["Inhalational MgSO4"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Newborns with documented persistent pulmonary hypertension as confirmed by echocardiography.\n* Neonates born at ≥ 35 wk. gestation with a birth weight of 2.5-4 kg\n* Neonates have to be connected to mechanical ventilation with an oxygenation index (OI) \\>30 on two occasions at least 15 min apart.\n* The echocardiogram had to show a predominant right-to-left or bidirectional shunt (through ductus arteriosus and/or foramen oval) and/or tricuspid regurgitant jet with a pressure gradient ≥ 2/3 of the systemic systolic blood pressure.\n\nExclusion Criteria:\n\n* Infants of parents who refuse to give informed consent.\n* Infants of mothers who receive magnesium sulfate within 48 h before labor.\n* Congenital heart diseases other than patent ductus arteriosus (PDA) and foramen ovale.\n* Major congenital anomalies, including congenital diaphragmatic hernia and lung hypoplasia.\n* Prior need for cardiopulmonary resuscitation\n* Mean arterial blood pressure (MABP) \\< 35 mmHg despite therapy with volume infusions and vasoactive inotropes.\n* Impaired kidney function; and prior administration of pulmonary vasodilators or prior administration of surfactant.","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Hour","maximumAge":"3 Days","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Airway Pressure (cm H2O)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.1","spread":"1.29"},{"groupId":"OG001","value":"13.8","spread":"1.18"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.7","spread":"1"},{"groupId":"OG001","value":"13.25","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":"1.27"},{"groupId":"OG001","value":"13.8","spread":"1.24"}]}]}]},{"type":"PRIMARY","title":"Fraction of Inspired Oxygen (FiO2) (%)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":"0"},{"groupId":"OG001","value":"100","spread":"0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96.5","spread":"5.8"},{"groupId":"OG001","value":"97.5","spread":"4.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"96","spread":"5.9"},{"groupId":"OG001","value":"97","spread":"5.7"}]}]}]},{"type":"PRIMARY","title":"PaO2 (mmHg)","description":"kPa x 7.5 converts to the equivalent PaO2 in mmHg","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.45","spread":"2"},{"groupId":"OG001","value":"38.35","spread":"1.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54.8","spread":"5.43"},{"groupId":"OG001","value":"51.45","spread":"3.46"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.45","spread":"7.56"},{"groupId":"OG001","value":"60.75","spread":"5.9"}]}]}]},{"type":"PRIMARY","title":"Tracking Changes in the Oxygenation Index (OI)","description":"OI evaluates both oxygenation and ventilatory support, aiding decisions on Extracorporeal Membrane Oxygenation (ECMO) necessity in newborns with PPHN. OI calculated as (Mean Airway Pressure (cm H2O) x Fraction of Inspired Oxygen (%) x 100) ÷ (PaO2 (kPa) x 7.5).\n\nOI is routinely used as an indicator of severity of hypoxemic respiratory failure (HRF) in neonates, with an arbitrary cutoff of 15 or less for mild HRF, between 16 and 25 for moderate HRF, between 26 and 40 for severe HRF, and more than 40 for very severe HRF","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"34.3","spread":"2.4"},{"groupId":"OG001","value":"34.1","spread":"2.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.2","spread":"2.6"},{"groupId":"OG001","value":"25.1","spread":"2.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.75","spread":"2.9"},{"groupId":"OG001","value":"22.1","spread":"2.19"}]}]}]},{"type":"SECONDARY","title":"the Variations in Mean Arterial Blood Pressure (MABP)","description":"Both systolic and diastolic pressure are used to calculate MABP.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"45.8","spread":"2.7"},{"groupId":"OG001","value":"45.7","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.6","spread":"3.2"},{"groupId":"OG001","value":"48.6","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"56.8","spread":"3.3"},{"groupId":"OG001","value":"53.6","spread":"2.4"}]}]}]},{"type":"SECONDARY","title":"the Alterations in Serum Magnesium Levels (mmol/L)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.92","spread":"0.1"},{"groupId":"OG001","value":"0.93","spread":"0.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"0.17"},{"groupId":"OG001","value":"3.6","spread":"0.18"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":[]}}}